Yep and nothing at all that will move the stock price in the least. We will languish around 1.30-1.40 for the considerable future. It is beyond frusturationg.
You wont hear a word about MND-2119 from Amarin in any market until pricing gets nailed down in the EU for the current formulation. Having a better, likely more cost effective, version active in the pipeline or approved in other markets while negotiating a higher price on an older tech is bad strategy. Likely you'll just get told to pack it up and come back when you got the new version available or price the current product the same. Same with an AG.
News 
Market Data 
Discover 
